What is Raltegravir?

Category: Prescription Drugs

Most popular types: Isentress

false

Raltegravir is an integrase transfer inhibitor antiretroviral agent used in the treatment of HIV-1 infection in combination with other antiretroviral agents.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 145 51
Support immune health 6 3
Acquired immune deficiency syndrome 2 1
Increase effect of another treatment 2 2
Myalgic encephalomyelitis/chronic fatigue syndrome 1 1
Participate in clinical trial 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
6
Mild
9
None
40

Commonly reported side effects and conditions associated with Raltegravir

Side effect Patients
Headaches 4
Diarrhea 2
Nausea 2
Agitation 1
Anxious mood 1
Chills 1

Show all 21 reported side effects

Dosages

Based on patients currently taking Raltegravir

Dosage Patients
400 mg twice daily 6
800 mg daily 4
400 mg daily 2

Why patients stopped taking Raltegravir

Multiple reasons could be selected

Reason Patients
Doctor's advice 11
Other 6
Course of treatment ended 4
Change in health plan coverage 2
Did not seem to work 1
Expense 1
Side effects too severe 1
See all 21 patients who've stopped taking Raltegravir

Duration

Currently taking Raltegravir

Duration Patients
6 months - 1 year 2
2 - 5 years 5
5 - 10 years 5

Stopped taking Raltegravir

Duration Patients
Less than 1 month 2
1 - 6 months 1
6 months - 1 year 3
1 - 2 years 5
2 - 5 years 5
5 - 10 years 5
Adherence
Adherence Evaluations
Always 43
Usually 11
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 19
Not at all hard to take 34
Cost per month
Cost per month Evaluations
$200+ 5
$100-199 1
$50-99 3
$25-49 6
< $25 18
Not specified 22

What people switch to and from

Patients started taking Raltegravir after stopping:

Treatment Patients
Abacavir-lamivudine (Epzicom) 1
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 1
Darunavir (Prezista) 1
Efavirenz-Emtricitabine-Tenofovir (Atripla) 1
Nevirapine (Viramune) 1

Show all 7 treatments patients report switching from

Patients stopped taking Raltegravir and switched to:

Treatment Patients
Triumeq 3
Abacavir-lamivudine-zidovudine (Trizivir) 1
Last updated:

9 patient evaluations for Raltegravir

Dec 12, 2016 (Started Feb 03, 2011)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily

  • 0 helpful marks

Aug 2, 2014 (Started Mar 15, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (peripheral neuritis)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Aug 8, 2012 (Started Jun 17, 2010)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    Mild (chills, headaches)
  • Adherence
    Usually
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Cost: $25-49 monthly
Side effects: headaches, chills

Jun 28, 2010 (Started Jun 17, 2010)

  • Effectiveness
    Can't tell (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (chills, headaches)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Advice & Tips: At the beginning I did not feel any strong secondary reactions. But by the end of the first week I started to feel more headaches and bone pain. Felt like getting a bad cold but it didn't really settle in. Second week, discomfort is lower and energy levels coming back again.
Cost: $25-49 monthly
Side effects: headaches, chills

  • 0 helpful marks
Last updated:
Showing 3 of 9 patient evaluations for Raltegravir